Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

BACKGROUND: This prospective study investigated the superiority of transarterial chemoembolization (TACE) with miriplatin over TACE with epirubicin regarding overall survival (OS) in patients with unresectable hepatocellular carcinoma (HCC). METHODS: Patients with unresectable HCC were randomized 1:...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Gastroenterol
मुख्य लेखकों: Ikeda, Masafumi, Kudo, Masatoshi, Aikata, Hiroshi, Nagamatsu, Hiroaki, Ishii, Hiroshi, Yokosuka, Osamu, Torimura, Takuji, Morimoto, Manabu, Ikeda, Kenji, Kumada, Hiromitsu, Sato, Tosiya, Kawai, Ikuko, Yamashita, Toru, Horio, Hiroshi, Okusaka, Takuji
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer Japan 2017
विषय:
Original Article—Liver, Pancreas, and Biliary Tract
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846877/
https://ncbi.nlm.nih.gov/pubmed/28766016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-017-1374-6
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन